Search
Search Results
##search.searchResults.foundPlural##
-
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1892PDF: 862HTML: 1597 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2499PDF: 895HTML: 2472 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1695PDF: 527HTML: 170 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1956Suppl. Files: 904HTML: 441PDF: 763 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2386PDF: 1046HTML: 5081Cover Letter: 177Figure 2: 174Figure 1: 183Figure 3: 209Figure 4: 179Figure Legend: 194Table 1: 201Table 2: 194Table 3: 191 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
949PDF: 672HTML: 166 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
9018PDF: 3281HTML: 1410 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2863PDF: 1851HTML: 3694Pellagatti Fig 1: 228Pellagatti Fig. 2: 221 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2528PDF: 1334HTML: 1803CoverLetter: 191 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3356PDF: 1272HTML: 8145 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
721PDF: 266Html: 36 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1500PDF: 925Suppl. Files: 463HTML: 248 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1865PDF: 1188HTML: 258 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1798PDF: 892HTML: 389Fig1: 248Fig.2: 261Fig. 3: 199Fig. 5: 211Fig. 4: 234 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2427PDF: 1018HTML: 1655Fig 1: 199Tab I: 224Cover Letter: 218 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3430PDF: 1503HTML: 4018 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4321PDF: 1505HTML: 8524 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
967PDF: 529HTML: 217 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2721PDF: 964HTML: 563 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1817PDF: 1096HTML: 262 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1731PDF: 751HTML: 2348 -
Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM):Implications for Clinical Practice OGTT concordance rate in thalassemia major
710PDF: 546Html: 122 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2373PDF: 1023HTML: 7630Untitled: 291Fig2: 194Fig3: 187Fig4: 197 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1316PDF: 908HTML: 325 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3995PDF: 1135HTML: 463 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
2798PDF: 1011HTML: 81 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2156PDF: 1939HTML: 357 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1401PDF: 778HTML: 534 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2687PDF: 763HTML: 2320 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
911PDF: 657Suppl. Files: 135HTML: 117 -
FIRST TUNISIAN CLUSTER ADMISSIONS OF CRITICALLY ILL PATIENTS WITH MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) : Multisystem inflammatory syndrome in children (MIS-C)
1380PDF: 533HTML: 200 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1363PDF: 591Suppl. Files: 362HTML: 163 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1659PDF: 809HTML: 223







